A Japanese mid-tier securities firm was reported to have maintained its Neutral rating on Tsumura & Co. while raising its target price from ¥3,900 to ¥4,000.
A Japanese mid-tier securities firm was reported to have maintained its Neutral rating on Tsumura & Co., while its target price was raised to ¥4,000. The previous target price was ¥3,900, so this represents an increase.
The article reports that, as of the previous day, 28 October, the rating consensus was 3.4 (5 analysts), indicating Neutral, while the target price consensus was ¥4,314 (also based on 5 analysts).
The information associated with Tsumura & Co. (ticker 4540) lists Kissei Pharmaceutical Co., Ltd., Seikagaku Corporation, Zeria Pharmaceutical Co., Ltd. and Rohto Pharmaceutical Co., Ltd. as related stocks.